Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: JUNE ISSUE PUBLISHED
  • JUNE 2021 Issue has been successfully launched on 1 June 2021.

Abstract

INHALED AMPHOTERICIN B FOR ASPERGILLOSIS

*Giphy Susan Varghese, Santa Treasa Cyriac, Madhumitha Arumugam

ABSTRACT

Aspergillus infection remains a supreme cause for mortality and morbidity in organ transplant recipients, immunocompromised and critically ill patients. Although Amphotericin B, Echinocandins and mold active Triazoles are the mainstay treatment options for aspergillosis, Amphotericin B inhalation has been effectively used as both treatment and prophylactic agent in various forms of aspergillosis. Amphotericin B administration via aerosols to lungs is associated with high pulmonary drug concentration and minimal systemic side effects. The common side effects are cough, nausea, vomiting and bronchospasm.

Keywords: Amphotericin B, Fungal infection, Aspergillosis, Nebulisation.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More